logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

医疗保健精选——Moderna日本早期新冠疫苗试验接种首位参与者;基因编辑公司股价攀升

Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest

Jan 21, 2021

Life Science

Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout

Jan 12, 2021

Life Science

医疗保健精选——杰富瑞上调CVS药店的目标股价,软银入股生物科技公司Pacific Biosciences

Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences

Jan 9, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

Dec 22, 2020

Life Science

Healthcare Roundup – U.S. prepares for mass inoculations as COVID-19 vaccine rolls out, Bahrain OK’s Chinese COVID-19 vaccine for use

Dec 14, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces Adoption of Advance Notice Bylaw and Shareholder Rights Plan as well as Transitions in its Board of Directors

Dec 11, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

Nov 27, 2020

Life Science

医疗保健精选——辉瑞和BioNTech新冠疫苗最终有效率达95%;FDA批准首个在家使用的新冠病毒试剂

Healthcare Roundup – Pfizer (PFE), BioNTech (BNTX) vaccine is 95% effective in final analysis; FDA authorizes first at-home rapid COVID-19 test

Nov 18, 2020

Life Science

医疗保健精选——Sorrento申请新冠抗体鼻喷雾剂的新药试验;欧盟与辉瑞和BioNTech接近达成新冠疫苗供应协议

Healthcare Roundup – Sorrento files IND for antibody nasal spray for COVID-19; EU next to reach deal for Pfizer, BioNTech vaccine

Nov 12, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership

Nov 10, 2020

Life Science

Healthcare Roundup – Futures add to big gains on vaccine hopes after Pfizer interim data, China vaccine trial suspended after ‘severe adverse event’

Nov 9, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Closing of Debt Settlement

Oct 28, 2020

Life Science

Healthcare Roundup – CytoDyn to file marketing application for leronlimab, Takeda submits supplemental application for Cabometyx

Oct 27, 2020

Life Science

医疗保健精选——CytoDyn的leronlimab治疗新冠患者的实验取得成功,Novavax将展示COVID-19疫苗数据

Healthcare Roundup – CytoDyn study of leronlimab for COVID-19 passes first interim tollgate, Novavax to present COVID-19 vaccine data

Oct 21, 2020

Life Science

医疗保健综述-礼来/信达生物利妥昔单抗注射液在中国获得许可;辉瑞和BioNTech提交COVID-19候选疫苗滚动审查申请

Healthcare Roundup – Lilly/Innovent rituximab injection OK’d in China; BioNTech, Pfizer announce rolling submission for COVID-19 vaccine candidate

Oct 9, 2020

Life Science

Healthcare Roundup – Regeneron +2.3% after Trump praises drug, Aprea on go with early-stage study with APR-548

Oct 8, 2020

Life Science

Healthcare Roundup – Trump taking Regeneron antibody cocktail, Study of AstraZeneca COVID-19 vaccine resumes in Japan

Oct 2, 2020

Life Science

Healthcare Roundup – Analysts move to sidelines on Inovio on delay in pivotal COVID-19 vaccine study, JD.com’s Health-Care Business to go public in Hong Kong

Sep 29, 2020

Life Science

  • ‹‹ Previous
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada